| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 154.121 | 114.187 | 47.079 | 0 | 0 | 0 | 0 | 0 | 0 | 2.835 |
| Total Income - EUR | 154.126 | 147.145 | 48.551 | 960 | 0 | 0 | 144.152 | 0 | 0 | 32.735 |
| Total Expenses - EUR | 142.044 | 128.688 | 74.996 | 9.350 | 0 | 2.396 | 97.173 | -1.361 | 2.423 | 2.675 |
| Gross Profit/Loss - EUR | 12.081 | 18.457 | -26.445 | -8.389 | 0 | -2.396 | 46.979 | 1.361 | -2.423 | 30.060 |
| Net Profit/Loss - EUR | 10.148 | 15.476 | -27.053 | -8.389 | 0 | -2.396 | 46.979 | 1.361 | -2.423 | 29.078 |
| Employees | 8 | 7 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oncovit Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 120.307 | 99.590 | 92.060 | 84.632 | 0 | 74.473 | 75.384 | 73.443 | 71.052 | 68.499 |
| Current Assets | 27.569 | 23.541 | 5.385 | 2.286 | 0 | -5.186 | 39.181 | 19.466 | 13.355 | 25.600 |
| Inventories | 11.341 | 16.706 | 16.217 | 15.920 | 0 | 9.247 | 9.042 | 9.070 | 9.043 | 8.992 |
| Receivables | 2.475 | 2.913 | -14.120 | -13.861 | 0 | -14.433 | 30.052 | 10.202 | 4.143 | 2.952 |
| Cash | 13.753 | 3.922 | 3.287 | 227 | 0 | 0 | 88 | 194 | 169 | 13.655 |
| Shareholders Funds | 43.100 | 49.238 | 21.352 | 12.571 | 0 | 2.858 | 64.232 | 10.482 | -2.372 | 26.719 |
| Social Capital | 56 | 56 | 55 | 54 | 0 | 52 | 51 | 51 | 51 | 50 |
| Debts | 104.775 | 73.893 | 76.092 | 74.348 | 0 | 66.430 | 50.333 | 82.427 | 86.780 | 67.379 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Oncovit Srl